94 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
21 Unknown  Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial Hyperplasia
Condition: Endometrial Carcinoma
Intervention:
22 Recruiting Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma
Condition: Endometrial Carcinoma
Intervention: Dietary Supplement: Curcuphyt
23 Recruiting HuMax®-TF-ADC Safety Study in Patients With Solid Tumors
Conditions: Ovary Cancer;   Cervix Cancer;   Endometrium Cancer;   Bladder Cancer;   Prostate Cancer (CRPC);   Esophagus Cancer;   Lung Cancer(NSCLC)
Intervention: Drug: HuMax-TF-ADC
24 Recruiting A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
Condition: Endometrial Cancer
Interventions: Drug: Metformin;   Drug: Letrozole;   Drug: Everolimus
25 Unknown  Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery
Condition: Early Stage Endometrial Cancer
Interventions: Procedure: Upper vaginectomy;   Radiation: Post-operative brachytherapy;   Procedure: Standard procedures
26 Not yet recruiting A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
Condition: Endometrial Cancer
Intervention: Drug: BMN 673
27 Unknown  Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma
Condition: Endometrial Cancer
Intervention: Procedure: surgery
28 Unknown  Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: lymphadenectomy;   Procedure: therapeutic conventional therapy;   Procedure: Positron Emission Tomography/ Computed Tomography;   Radiation: fludeoxyglucose F 18
29 Recruiting Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: carboplatin and paclitaxel;   Other: observation
30 Recruiting Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
Conditions: Endometrial Cancer;   Gynecological Cancers
Intervention:
31 Recruiting Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Conditions: Hyperplasia;   Endometrial Cancer
Intervention: Device: Levonorgestrel IUD
32 Recruiting Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
Condition: Stage III-IV or Recurrent Endometrial Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
33 Unknown  Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Genetic: gene expression analysis;   Other: laboratory biomarker analysis;   Other: medical chart review;   Other: study of socioeconomic and demographic variables
34 Recruiting Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
Conditions: Complex Atypical Hyperplasia;   Endometrial Cancer
Intervention: Drug: Metformin
35 Unknown  Screening of Biomarkers on Endometrial Cancers
Condition: Endometrial Cancers
Intervention: Procedure: surgery
36 Unknown  Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Thunderbeat technology;   Procedure: Standard bipolar electrosurgery
37 Unknown  Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Genetic: RNA analysis;   Genetic: microarray analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: laboratory biomarker analysis
38 Unknown  Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With High-risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Pelvic and Para-Aortic Radiation 6MV Photon Beam Energy;   Radiation: High Dose Radiation
39 Recruiting Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: Dasatinib
40 Recruiting Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Conditions: Stage I Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Procedure: lymph node mapping;   Procedure: sentinel lymph node biopsy;   Drug: isosulfan blue;   Drug: indocyanine green solution;   Procedure: therapeutic conventional surgery;   Procedure: lymphadenectomy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years